Yıl: 2021 Cilt: 8 Sayı: 4 Sayfa Aralığı: 211 - 216 Metin Dili: İngilizce DOI: 10.5152/eurjrheum.2020.21199 İndeks Tarihi: 01-01-2022

Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients

Öz:
Objective: Behçet’s syndrome (BS) is a multisystem variable vessel vasculitis characterized by skin-mucosal lesions. It can also involve the eyes, blood vessels, joints, gastrointestinal system, urogenital system, and central nervous system. BS starts in the third or fourth decade and affects both genders equally. The disease is more severe in young men. Although the sensitivity of the pathergy test (PT) is decreasing today, it is still an important clue in the diagnosis of BS. We describe the characteristics of BS in our region, retrospectively. We also analyzed the effect of gender, age, family history, and skin PT positivity status on the difference of clinical involvement. Methods A total of 777 BS patients (391 women and 386 men; 40.0 ± 11.6 years old) who applied to our Rheumatology Department between January 2010 and June 2020 were included in the study. Results: Of the 777 patients, 391 were female (50.3%) and 386 were male (49.7%). The mean age at diagnosis was 30.3 ± 9.8 years. The proportion of patients with BS in their family was 10.2%. Of the 777 patients, 310 (39.9%) had only mucocutaneous symptoms. Other 467 patients (60.1%) had at least one of the ocular, musculoskeletal, vascular, neurologic, intestinal, or genitourinary involvement. Serious involvements such as eye, cardiovascular, and neurologic involvement were more common in male patients. Conclusion: BS has the different clinical phenotypes according to gender, age of onset, and skin PT positivity status. Gender influences on the major organ involvements such as eye, neurologic, and vascular.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2019: Behçet’s syndrome. Clin Exp Rheumatol. 2019;37:3-17.
  • 2. Esatoglu SN, Kutlubay Z, Hatemi G. Highlights of the 18th international conference on Behçet’s syndrome. Clin Exp Rheumatol. 2018;36:3-12.
  • 3. Behcet H. Some observations on the clinical picture of the so-called triple symptom complex. Dermatology. 1940;81:73-83. [Crossref]
  • 4. Behget H. Uber rezidivierende, aphthose, durch ein virus verursachte geschwure am mund, am auge und an den genitalien. Dermatol Wochensch. 1937;105:1152-7.
  • 5. Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803-6. [Crossref]
  • 6. Li C, Li L, Wu X, et al. Clinical manifestations of Behçet’s disease in a large cohort of Chinese patients: Gender- and age-related differences. Clin Rheumatol. 2020;39:2493-3. [Crossref]
  • 7. Onder M, Gürer MA. The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venerol. 2001;15:126-36. [Crossref]
  • 8. Seyahi E. Phenotypes in Behçet’s syndrome. Intern Emerg Med. 2019;14:677-89. [Crossref]
  • 9. Davatchi F, Chams-Davatchi C, Ghodsi Z, et al. Diagnostic value of pathergy test in Behcet’s disease according to the change of incidence over the time. Clin Rheumatol. 2011;30:1151-5. [Crossref]
  • 10. Dilşen N, Koniçe M, Aral O, Ocal L, Inanç M, Gül A. Comparative study of the skin pathergy test with blunt and sharp needles in Behçet’s disease: Confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis. 1993;52:823-5. [Crossref]
  • 11. Chang HK, Cheon KS. The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean Med Sci. 2002;17:371-4. [Crossref]
  • 12. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR‐ICBD), Davatchi F, Assaad‐Khalil S, et al. The international criteria for Behçet’s disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338-47.
  • 13. Wechsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N, Kansu E, Yazıcı H, et al. Criteria for diagnosis of Behçet’s disease. International study Group for Behçet’s Disease. Lancet. 1990;335:1078-80.
  • 14. Bang DS, Oh SH, Lee KH, Lee ES, Lee SN. Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci. 2003;18:231-5. [Crossref]
  • 15. Davatchi F, Shahram F, Chams-Davatchi C, Abdollahi BS, Shams H, Nadji A. Behcet’s disease: Is there a gender influence on clinical manifestations? Int J Rheum Dis. 2012;15:306-14. [ Crossref]
  • 16. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003;42:346-51. [Crossref]
  • 17. Davatchi F, Shahram F, Chams C, Chams H, Nadji A, Jamshidi AR. The influence of gender on the frequency of clinical symptoms in Behçet’s disease. Adv Exp Med Biol. 2003; 528:65-66.
  • 18. Yazici H, Tüzün Y, Pazarli H, et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis. 1984;43:783-9. [Crossref]
  • 19. Hamzaoui A, Jaziri F, Ben ST, et al. Comparison of clinical features of Behcet disease according to age in a Tunisian cohort. Acta Med Iran. 2014;52: 748-51.
  • 20. Ishido T, Horita N, Takeuchi M, et al. Clinical manifestations of Behçet’s disease depending on sex and age: Results from Japanese nationwide registration. Rheumatology (Oxford). 2017;56:1918-27. [Crossref]
  • 21. Kecici AS, Kutlubay Z, Serdaroglu S, Tuzun Y. Pathergy testing: Prospective comparison of dermatoscopic evaluation and naked eye examination. Intern Emerg Med. 2019;14:699-703. [Crossref]
  • 22. Ozdemir M, Bodur S, Engin B, Baysal I. Evaluation of application of multiple needle pricks on the pathergy reaction. Int J Dermatol. 2008;47:335-8. [Crossref]
  • 23. Gül A, Inanç M, Ocal L, Aral O, Koniçe M. Familial aggregation of Behçet’s disease in Turkey. Ann Rheum Dis. 2000;59:622-5. [Crossref]
  • 24. Karincaoglu Y, Borlu M, Toker SC, et al. Demographic and clinical properties of juvenile-onset Behçet’s disease: A controlled multicenter study. J Am Acad Dermatol. 2008;58:579-84. [Crossref]
  • 25. Akpolat T, Koç Y, Yeniay I, et al. Familial Behçet’s disease. Eur J Med. 1992;1:391-5.
  • 26. Ceylan Kalın Z, Sarıcaoğlu H, Yazici S, Aydoğan K, Bülbül Başkan E. Clinical and demographical characteristics of familial Behçet’s disease (southeast Marmara region). Dermatology. 2019;235:407-12. [Crossref]
  • 27. Fresko I, Soy M, Hamuryudan V, et al. Genetic anticipation in Behçet’s syndrome. Ann Rheum Dis. 1998;57:45-8. [Crossref]
  • 28. Arias IM, Ramos-Casals M, Espinosa G, Reyes R. Sacroiliitis and Behçet disease. An Med Interna. 2006;23:300. [Crossref]
  • 29. Dubost J, Sauvezie B, Galtier B, Bussière JL, Rampon S. Behcet’s syndrome and ankylosing spondylarthritis. Rev Rhum Mal Osteoartic. 1985;52:457-61.
  • 30. Nadji A, Davatchi F, Shahram F, et al. In Zouboulis CC (ed.): The Comparison of Ankylosing Spondylitis in Behçet’s Disease and Normal Population, in Adamantiades-Behçet’s Disease, Boston, MA: Springer US, 2003:449-53.
  • 31. Yazici H, Tuzlaci M, Yurdakul S. A controlled survey of sacroiliitis in Behçet’s disease. Ann Rheumat Dis. 1981;40:558-9. [Crossref]
  • 32. Tosum M. Coexisting ankylosing spondylitis and Behcet’s disease. Clin Rheumatol. 1996;15:619-20.
  • 33. Karkucak M, Cakirbay H, Capkin E, et al. The prevalence of ankylosing spondylitis in the Eastern black sea region of Turkey. Eur J Gen Med. 2011;8:40-5.
  • 34. Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: A field study. J Rheumatol. 1998;25:2445-9.
  • 35. Capkin E, Cakirbay H, Karkucak M, et al. Prevalence of rheumatoid arthritis in the Eastern black sea region of Turkey. Int J Rheumat Dis. 2010;13:380-4. [Crossref]
  • 36. Gunaydin I, Ustündağ C, Kaner G, et al. The prevalence of Sjögren’s syndrome in Behçet’s syndrome. J Rheumatol. 1994;21:1662-4.
  • 37. Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983-9. [ Crossref]
APA Gürbüz C, Yalcin Kehribar D, Ozgen M (2021). Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. , 211 - 216. 10.5152/eurjrheum.2020.21199
Chicago Gürbüz Cemal,Yalcin Kehribar Demet,Ozgen Metin Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. (2021): 211 - 216. 10.5152/eurjrheum.2020.21199
MLA Gürbüz Cemal,Yalcin Kehribar Demet,Ozgen Metin Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. , 2021, ss.211 - 216. 10.5152/eurjrheum.2020.21199
AMA Gürbüz C,Yalcin Kehribar D,Ozgen M Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. . 2021; 211 - 216. 10.5152/eurjrheum.2020.21199
Vancouver Gürbüz C,Yalcin Kehribar D,Ozgen M Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. . 2021; 211 - 216. 10.5152/eurjrheum.2020.21199
IEEE Gürbüz C,Yalcin Kehribar D,Ozgen M "Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients." , ss.211 - 216, 2021. 10.5152/eurjrheum.2020.21199
ISNAD Gürbüz, Cemal vd. "Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients". (2021), 211-216. https://doi.org/10.5152/eurjrheum.2020.21199
APA Gürbüz C, Yalcin Kehribar D, Ozgen M (2021). Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. European Journal of Rheumatology, 8(4), 211 - 216. 10.5152/eurjrheum.2020.21199
Chicago Gürbüz Cemal,Yalcin Kehribar Demet,Ozgen Metin Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. European Journal of Rheumatology 8, no.4 (2021): 211 - 216. 10.5152/eurjrheum.2020.21199
MLA Gürbüz Cemal,Yalcin Kehribar Demet,Ozgen Metin Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. European Journal of Rheumatology, vol.8, no.4, 2021, ss.211 - 216. 10.5152/eurjrheum.2020.21199
AMA Gürbüz C,Yalcin Kehribar D,Ozgen M Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. European Journal of Rheumatology. 2021; 8(4): 211 - 216. 10.5152/eurjrheum.2020.21199
Vancouver Gürbüz C,Yalcin Kehribar D,Ozgen M Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients. European Journal of Rheumatology. 2021; 8(4): 211 - 216. 10.5152/eurjrheum.2020.21199
IEEE Gürbüz C,Yalcin Kehribar D,Ozgen M "Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients." European Journal of Rheumatology, 8, ss.211 - 216, 2021. 10.5152/eurjrheum.2020.21199
ISNAD Gürbüz, Cemal vd. "Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients". European Journal of Rheumatology 8/4 (2021), 211-216. https://doi.org/10.5152/eurjrheum.2020.21199